COMMUNIQUÉS West-GlobeNewswire

ALK upgrades its full-year revenue outlook
02/05/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ) today announced that the 2024 full-year financial outlook has been updated. Revenue is now expected to grow by 10-13% in local currencies (previously: 9-12%). The full-year financial [...]
AB Science : The Paris Court of Appeal confirms the acquittal of the CEO of AB Science, Alain Moussy, and reduces the amount of the financial penalty imposed on AB Science
02/05/2024
PRESS RELEASE THE PARIS COURT OF APPEAL CONFIRMS THE ACQUITTAL OF THE CEO OF AB SCIENCE, ALAIN MOUSSY, AND REDUCES THE AMOUNT OF THE FINANCIAL PENALTY IMPOSED ON AB SCIENCE Paris, May 2, 2024, 7pm CET AB Science SA ( [...]
AB Science : La Cour d’Appel de Paris confirme la mise hors de cause du Président Directeur Général d’AB Science, Alain Moussy, et diminue le montant de la sanction imposée à AB Science
02/05/2024
COMMUNIQUE DE PRESSE LA COUR D’APPEL DE PARIS CONFIRME LA MISE HORS DE CAUSE DU PRESIDENT DIRECTEUR GENERAL D’AB SCIENCE, ALAIN MOUSSY, ET DIMINUE LE MONTANT DE LA SANCTION IMPOSEE A AB SCIENCE Paris, 2 mai 2024, 19h AB [...]
Retrieve Medical Announces Significant Results from Physician Burnout Study
02/05/2024
BEDMINSTER, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) unveils significant breakthroughs from its recent examination into Physician Burnout. The study has illuminated a [...]
Ibogaine By David Dardashti Pioneers Work on Quantum Electrodynamics Prototype
02/05/2024
A Groundbreaking Innovation Set To Make A Difference MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- Ibogaine by David Dardashti looks to revolutionize the field of ibogaine addiction treatment through its recent exploration of [...]
Acentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access Commission
02/05/2024
MCLEAN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, [...]
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2023
02/05/2024
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2023 Nantes, le 2 mai 2024 – OSE Immunotherapeutics SA ( ISIN: FR0012127173; Mnémo: OSE) annonce la mise à disposition de son [...]
Number of voting rights as of April 30, 2024
02/05/2024
Nicox SA Société anonyme with a registered capital of € 50,299,694 Head Office: Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois – 06410 Biot R.C.S. ANTIBES 403.942.642 On May 2 nd , 2024, MONTHLY [...]
Nombre de droits de vote au 30 avril 2024
02/05/2024
Nicox SA Société anonyme au capital de 50 299 694 euros Siège social : Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois, 06410 Biot R.C.S. ANTIBES 403.942.642 Le 02 mai 2024, PUBLICATION MENSUELLE DU NOMBRE [...]
Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe
02/05/2024
Extended contract now covers a total of 11 European countries Crossject will receive milestone payments of up to €1 million in total, upon marketing authorizations Crossject will sell ZEPIZURE® to the partner with a [...]
Crossject signe une extension géographique de l'accord de commercialisation de ZEPIZURE® en Europe
02/05/2024
Le contrat couvre désormais un total de 11 pays européens Crossject recevra des paiements d’étape pour un montant total pouvant aller jusqu’à un million d’euros, dès l’obtention des autorisations de mise sur le marché [...]
CirrusMD's Physician-first Virtual Care Now Accessible Via Partnership with Blackwell Captive Solutions, Changing Healthcare Delivery in the U.S.
02/05/2024
ful.Health Partners with Blackwell Captive Solutions to Deliver Innovative Cost-Containment Solutions, Featuring CirrusMD's Physician-Led Care, Ensuring Payers Benefit from Enhanced Savings and Superior Healthcare. [...]
Genmab Announces Financial Results for the First Quarter of 2024
02/05/2024
May 2, 2024 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2024 Highlights The U.S. Food and Drug Administration (U.S. FDA) granted Priority Review for the supplemental Biologics License [...]
American Nurses Association Presents Nurses Week 2024 – Nurses Make the Difference
02/05/2024
This year's theme, "Nurses Make the Difference," honors the incredible nurses who embody the spirit of compassion and care in every health care setting. SILVER SPRING, MD, May 02, 2024 (GLOBE NEWSWIRE) -- The American [...]
Team Member Feedback Earns HealthEquity Workplace Culture Recognition
02/05/2024
For the fourth consecutive year, team members' feedback has propelled HealthEquity to be recognized for cultural excellence DRAPER, Utah, May 02, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation’s [...]
Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
02/05/2024
ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI ) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic [...]
Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02/05/2024
New role enhances company’s strong leadership team and solidifies commitment to ongoing clinical innovation DOYLESTOWN, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “ [...]
KFSH&RC Ranked Top Valuable Healthcare Brand in Saudi Arabia and Middle East
02/05/2024
RIYADH, Saudi Arabia, May 02, 2024 (GLOBE NEWSWIRE) -- KFSH&RC tops the healthcare sector in the Kingdom of Saudi Arabia and the Middle East, recognizing it as the most valuable healthcare brand in these regions for [...]
Kriya Announces Three Presentations at the 2024 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
02/05/2024
– Kriya is developing KRIYA-825 as a potential one-time gene therapy expressing a fusion protein inhibiting the activity of complement C3 and C5 for the treatment of Geographic Atrophy – PALO ALTO, Calif. and RESEARCH [...]

Pages